Citations

Showing 10 of 108094 citations.

The unfolding landscape of the congenital myasthenic syndromes
Engel, Andrew G. , Shen, Xin‐Ming , Selcen, Duygu

Mayo Clinic

Annals of the New York Academy of Sciences | January 22, 2018 | Volume: 1413 | Issue: 1 | Pages: 25-34

10.1111/nyas.13539 | PMID 29355968 Get It

AbstractCongenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is impaired by one or more specific mechanisms. Since the advent of next‐generation sequencing methods, the discovery of novel CMS targets and phenotypes has proceeded at an accelerated rate. Here, we review the current classification of CMS and describe our findings in five of these targets identified and investigated in our laboratory in the past 5 years. Defects in LRP4 hinder synaptic development and maintenance; the defects in PREPL are predicted to diminish filling of the synaptic vesicle with acetylcholine; and defects in SNAP25, Munc13‐1, and synaptotbrevin‐1 impede synaptic vesicle exocytosis.
Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves
Dvir, Danny , Bourguignon, Thierry , Rosenhek, Raphaël , Webb, John G. , Treede, Hendrik , Enriquez‐Sarano, Maurice , Feldman, Ted , Wijeysundera, Harindra C. , Topilsky, Yan , Aupart, Michel, Reardon, Michael J. , Szeto, Wilson Y. , Gammie, James S. , Yoganathan, Ajit P. , Arbel, Yaron , Borger, Michael A. , Simonato, Matheus , Reisman, Mark, Makkar, Raj , Abizaid, Alexandre , Dahle, Gry , Aldea, Gabriel S. , Leipsic, Jonathon , Pîbarot, Philippe , Moat, Neil, Mack, Michael J. , Leon, Martin B. , Topilsky, Yan , Sarano, Maurice E, Pibarot, Phillippe , Enriquez-Sarano, Maurice , Otto, Catherine M , Hahn, Rebecca T , Mackensen, G. Burkhard , Kornowski, Ran , McCabe, James M , Kappetein, A. Pieter , Topilsky, Yan , Reardon, Michael J , Abizaid, Alexandre

Mayo Clinic

Circulation | January 22, 2018 | Volume: 137 | Issue: 4 | Pages: 388-399

10.1161/circulationaha.117.030729 | PMID 29358344 Get It

Bioprostheses are prone to structural valve degeneration, resulting in limited long-term durability. A significant challenge when comparing the durability of different types of bioprostheses is the lack of a standardized terminology for the definition of a degenerated valve. This issue becomes especially important when we try to compare the degeneration rate of surgically inserted and transcatheter bioprosthetic valves. This document, by the VIVID (Valve-in-Valve International Data), proposes practical and standardized definitions of valve degeneration and provides recommendations for the timing of clinical and imaging follow-up assessments accordingly. Its goal is to improve the quality of research and clinical care for patients with deteriorated bioprostheses by providing objective and strict criteria that can be utilized in future clinical trials. We hope that the adoption of these criteria by both the cardiological and surgical communities will lead to improved comparability and interpretation of durability analyses.
Parkinson disease with and without Dementia: A prevalence study and future projections
Savica, Rodolfo , Rocca, Walter A. , Bower, James H., Grossardt, Brandon R. , Rocca, Walter A

Mayo Clinic

Movement Disorders | January 22, 2018 | Volume: 33 | Issue: 4 | Pages: 537-543

10.1002/mds.27277 | PMID 29356127 Get It

ABSTRACTBackground: Limited population‐based information is available on the co‐occurrence of dementia and PD. However, projecting the prevalence of PD with and without dementia during the next 50 years is crucial for planning public‐health and patient‐care initiatives.Objectives: The objective of this study was to project the prevalence of PD with and without dementia in the United States by 2060.Methods: We used the Rochester Epidemiology Project medical records‐linkage system to identify all persons with PD with or without dementia residing in Olmsted County, Minnesota, on January 1, 2006. A movement disorders specialist reviewed the complete medical records of each person to confirm the presence of PD. We calculated the age‐ and sex‐specific prevalence of PD with and without dementia and projected U.S. prevalence through 2060.Results: We identified 296 persons with PD with and without dementia on the prevalence date (187 men, 109 women); the overall prevalence increased with age from 0.01% (30‐39 years) to 2.83% (≥90 years). The prevalence of PD without dementia increased with age from 0.01% (30‐39 years) to 1.25% (≥90 years). The prevalence of PD with dementia increased with age from 0.10% (60‐69 years) to 1.59% (≥90 years). The prevalence was higher in men than in women for all subtypes and all age groups. We project by 2060 an approximate doubling of the number of persons with PD without dementia and a tripling of the number of persons with PD with dementia in the United States.Conclusions: The prevalence of PD with and without dementia increases with age and is higher in men than women. We project that the number of persons with PD in the United States will increase substantially by 2060. © 2018 International Parkinson and Movement Disorder Society
Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study
Buse, Dawn C. , Powers, Scott W. , Gelfand, Amy A. , VanderPluym, Juliana H. , Fanning, Kristina M. , Reed, Michael L. , Adams, Aubrey Manack, Lipton, Richard B. , Gelfand, Amy A , VanderPluym, Juliana

Mayo Clinic

Headache: The Journal of Head and Face Pain | January 22, 2018 | Volume: 58 | Issue: 4 | Pages: 512-524

10.1111/head.13254 | PMID 29355924 Get It

Objective To assess the impact of parental migraine on adolescents (aged 13‐21 years) living within the parental home from the adolescent's perspective. Background Family members are affected by their parent's migraine. We surveyed adolescents on the social, academic, and emotional effects of their parent's migraine. Methods The Chronic Migraine Epidemiology and Outcomes (CaMEO) study was a longitudinal Web‐based study with cross‐sectional modules designed to assess migraine symptoms, severity, frequency, and disability; migraine‐related consulting practices, healthcare utilization, medication use, comorbid health conditions, and family related burden associated with migraine. The Family Burden Module (adolescent version; FBM‐A) from the CaMEO study assessed parents with migraine and adolescent household members (dyads). Adolescents ranged in age from 13‐21 years and were living at home with their parent. The initial FBM‐A survey included 52 items covering five domains, which was refined and reduced by confirmatory factor analysis to 36 items covering four domains. Depression (9‐item Patient Health Questionnaire) and anxiety (7‐item Generalized Anxiety Disorder scale) were assessed. Item responses were stratified by parent migraine status (episodic migraine [EM], <15 headache days/month; chronic migraine [CM], ≥15 headache days/month). Frequencies of activities/events missed because of parental headache were categorized as ≥1 time or ≥4 times/previous 30 days. Results The sample included 1,411 parent‐adolescent dyads (parent with EM, n = 1,243 [88.1%]; parent with CM, n = 168 [11.9%]). Burden due to a parent's migraine was reported in four domains based on 36 items including: Loss of Parental Support and Reverse Caregiving (5 items); Emotional Experience (13 items); Interference with School (4 items); and Missed Activities and Events (14 items). Across domains, perceived burden was greater for adolescents of parents with CM vs EM. Rates of moderate‐to‐severe anxiety symptoms were higher among adolescents of parents with CM (6.2 vs 11.3%, P = .01), while moderate‐to‐severe depression symptom rates were similar (5.5 vs 8.9%, P = .08). More adolescents of CM vs EM parents reported having a headache within the previous 3 months ( P < .001). Conclusions Parental migraine negatively impacts adolescent children, extending our understanding of the family burden of migraine and emphasizing the potential benefit to children of optimizing migraine care.
Testing the Impact of Mixed‐Mode Designs (Mail and Web) and Multiple Contact Attempts within Mode (Mail or Web) on Clinician Survey Response
Beebe, Timothy J. , Jenkins, Sarah M. , Lackore, Kandace A. , Jacobson, Robert M. , Beebe, Timothy J. , Rutten, Lila J. Finney

Mayo Clinic

Health Services Research | January 22, 2018 | Volume: 53 | Issue: S1 | Pages: 3070-3083

10.1111/1475-6773.12827 | PMID 29355920 Get It

Objective To compare response rate and nonresponse bias across two mixed‐mode survey designs and two single‐mode designs. Data Sources This experiment was embedded in a clinician survey of knowledge and attitudes regarding HPV vaccination ( n = 275). Study Design Clinicians were randomly assigned one of two mixed‐mode (mail/web or web/mail) or single‐mode designs (mail‐only/web‐only). Differences in response rate and nonresponse bias were assessed. Principal Findings Using a multiple‐contact protocol increased response, and sending a web survey first provided the more rapid response. Overall, the mixed‐mode survey designs generated final response rates approximately 10 percentage points higher than their single‐mode counterparts, although only the final response differences between the mail‐only and web/mail conditions attained statistical significance (32.1 percent vs. 48 percent, respectively; p = .005). Observed differences did not result in nonresponse bias. Conclusions Results support mixing modes of survey administration and web‐based data collection in a multiple contact survey data collection protocol.
Integrated transcriptomic and regulatory network analyses identify microRNA-200c as a novel repressor of human pluripotent stem cell-derived cardiomyocyte differentiation and maturation
Hao, Baixia , Guan, Daogang , Li, Mulin Jun , Lu, Jun, Yang, Yong , Wu, Binbin , Wu, Stanley Chun-ming, Webb, Sarah , Liang, Yan , Yao, Xiaoqiang , Wang, Junwen , Yan, Bin , Wang, Junwen , Poon, Ellen Ngar-Yun , Miller, Andrew L. , Boheler, Kenneth R.

Mayo Clinic

Cardiovascular Research | January 22, 2018 | Volume: 114 | Issue: 6 | Pages: 894-906

10.1093/cvr/cvy019 | PMID 29373717 Get It

Contemporary Management of Localized Resectable Pancreatic Cancer
Kommalapati, Anuhya , Tella, Sri Harsha , Goyal, Gaurav , Mahipal, Amit , Ma, Wen Wee, Mahipal, Amit , Goyal, Guarav , Kommalapati, Anuhya , Ma, Wen

Mayo Clinic

Cancers | January 22, 2018 | Volume: 10 | Issue: 1 | Pages: 24

10.3390/cancers10010024 | PMID 29361690 Get It

Pancreatic cancer is the third most common cause of cancer deaths in the United States. Surgical resection with negative margins still constitutes the cornerstone of potentially curative therapy, but is possible only in 15–20% of patients at the time of initial diagnosis. Accumulating evidence suggests that the neoadjuvant approach may improve R0 resection rate in localized resectable and borderline resectable diseases, and potentially downstage locally advanced disease to achieve surgical resection, though the impact on survival is to be determined. Despite advancements in the last decade in developing effective combinational chemo-radio therapeutic options, preoperative treatment strategies, and better peri-operative care, pancreatic cancer continues to carry a dismal prognosis in the majority. Prodigious efforts are currently being made in optimizing the neoadjuvant therapy with a better toxicity profile, developing novel agents, imaging techniques, and identification of biomarkers for the disease. Advancement in our understanding of the tumor microenvironment and molecular pathology is urgently needed to facilitate the development of novel targeted and immunotherapies for this setting. In this review, we detail the current literature on contemporary management of resectable, borderline resectable and locally advanced pancreatic cancer with a focus on future directions in the field.
Effect of medium-chain triglycerides on liver fatty acid composition in alcoholics with or without cirrhosis
Malagelada, J. R., Linscheer, W. G., Houtsmuller, U.M.T., Vergroesen, A.J., Iber, Frank L., Shah, M.

Mayo Clinic

The American Journal of Clinical Nutrition | January 22, 2018 | Volume: 26 | Issue: 7 | Pages: 738-743

10.1093/ajcn/26.6.738 | PMID 4714385 Get It

Identifying patients at risk of inhospital death or hospice transfer for early goals of care discussions in a US referral center: the HELPS model derived from retrospective data
Romero‐Brufau, Santiago , Whitford, Daniel , Whitford, Kevin J. , Manning, Dennis M., Romero-Brufau, Santiago , Huddleston, Jeanne M.

Mayo Clinic

BMJ Open | January 22, 2018 | Volume: 8 | Issue: 1 | Pages: e015550

10.1136/bmjopen-2016-015550 | PMID 29358415 Get It

Objective Create a score to identify patients at risk of death or hospice placement who may benefit from goals of care discussion earlier in the hospitalisation. Design Retrospective cohort study to develop a risk index using multivariable logistic regression. Setting Two tertiary care hospitals in Southeastern Minnesota. Participants 92 879 adult general care admissions (50% male, average age 60 years). Primary and secondary outcome measures Our outcome measure was an aggregate of inhospital death or discharge to hospice. Predictor variables for the model encompassed comorbidities, nutrition status, functional status, demographics, fall risk, mental status, Charlson Comorbidity Index and acuity of illness on admission. Resuscitation status, race, geographic area of residence and marital status were added as covariates to account for confounding. Results Inhospital mortality and discharge to hospice were rare, with incidences of 1.2% and 0.8%, respectively. The Hospital End-of-Life Prognostic Score (HELPS) demonstrated good discrimination (C-statistic=0.866 in derivation set and 0.834 in validation set). The patients with the highest 5% of scores had an 8% risk of the outcome measure, relative risk 12.9 (10.9–15.4) when compared to the bottom 95%. Conclusions HELPS is able to identify patients with a high risk of inhospital death or need for hospice at discharge. These patients may benefit from early goals of care discussions.